Agustina Nicole Arbia Kalutich

Prof. Agustina Nicole Arbia Kalutich

Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSol Marcos
Sol Marcos
Luisa L BotellaLuisa L Botella
Luisa L Botella
VAVirginia Albiñana Albiñana
Virginia Albiñana Albiñana
Agustina Nicole Arbia KalutichAgustina Nicole Arbia Kalutich
Agustina Nicole Arbia Kalutich
ARAnna María de Rosales
Anna María de Rosales
Epistaxis is the most prevalent clinical symptom in Hereditary Haemorrhagic Telangiectasia (HHT), causing anaemia and decreasing the quality of life (QOL). Since 2013, in Hospital Universitario Fundación Alcorcón, more than 150 HHT patients have been treated by nose sclerotherapy on demand. This study shows the results of 105 patients treated with sclerotherapy between 2017 and 2019. HHT-ESS (epistaxis severity score) was used to measure the severity and frequency of epistaxis. QOL was determined before and after treatment by EuroQol-5D (EQ-5D) and the visual analogue scale (VAS) on the health condition. According to HHT-ESS before treatment, 22 patients presented mild, 35 moderate, and 47 severe epistaxes. Sclerotherapy significantly decreased the frequency and severity of epistaxis, with a significant drop of HHT-ESS in 4.6 points, from 6.23 ± 2.3 to 1.64 ± 1.6. Furthermore, the QOL significantly improved, the EQ-5D scale raised from 0.7 ± 0.26 pre- to 0.92 ± 0.16 post-treatment (p < 0.05). Additionally, VAS mean value showed a significant increase from 4.38 ± 2.4 to 8.35 ± 1.2. The QOL improvement was correlated with the ESS decrease. In conclusion, this study shows that on-demand sclerotherapy at the office significantly reduces HHT epistaxis as well as improved the patients’ QOL.

12 December 2022 in Journal of Clinical Images and Medical Case Reports
Verified
Journal Article
Closed access
GPGuillermo Plaza
Guillermo Plaza
MCMadrid Universidad Rey Juan Carlos
Madrid Universidad Rey Juan Carlos
Agustina Nicole Arbia KalutichAgustina Nicole Arbia Kalutich
Agustina Nicole Arbia Kalutich
Introduction and objective: Laryngeal leishmaniasis is a rare disease that should be considered in patients presenting with hoarseness or dyspnea having risk factors as immunodeficiency (systemic or local) and previous Leishmania infections

9 December 2022 in Journal of Clinical Images and Medical Case Reports
Verified
Journal Article
Closed access
GPGuillermo Plaza
Guillermo Plaza
MCMadrid Universidad Rey Juan Carlos
Madrid Universidad Rey Juan Carlos
Agustina Nicole Arbia KalutichAgustina Nicole Arbia Kalutich
Agustina Nicole Arbia Kalutich
Introduction and objective: Tympanic Membrane Cholesteatoma (TMC) is a rare pathology of unknown etiology which occurs more frequently in pediatric population, being the presentation in adults exceptional. Resection of the lesion is usually the surgical treatment through a transcanal approach.